CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer

CD4+ conventional T cells-related genes signature is a prognostic indicator for ovarian cancer

IntroductionIt is believed that ovarian cancer (OC) is the most deadly form of gynecological cancer despite its infrequent occurrence, which makes it one of the most salient public health concerns. Clinical and preclinical studies have revealed that intratumoral CD4+ T cells possess cytotoxic capabi...

Full description

Bibliographic Details
Main Authors:	Tian Hua, Deng-xiang Liu, Xiao-chong Zhang, Shao-teng Li, Peng Yan, Qun Zhao, Shu-bo Chen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-03-01
Series:	Frontiers in Immunology
Subjects:	ovarian cancer CD4+ conventional T cells prognostic signature tumor microenvironment immunotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1151109/full

Similar Items

Suppressive stroma-immune prognostic signature impedes immunotherapy in ovarian cancer and can be reversed by PDGFRB inhibitors
by: Dong Yang, et al.
Published: (2023-09-01)

Machine learning developed a CD8+ exhausted T cells signature for predicting prognosis, immune infiltration and drug sensitivity in ovarian cancer
by: Rujun Chen, et al.
Published: (2024-03-01)

Identification of a CD4+ conventional T cells-related lncRNAs signature associated with hepatocellular carcinoma prognosis, therapy, and tumor microenvironment
by: Lin Zhu, et al.
Published: (2023-01-01)

Identification of NAD+ Metabolism-Derived Gene Signatures in Ovarian Cancer Prognosis and Immunotherapy
by: Liang Lin, et al.
Published: (2022-06-01)

A macrophage related signature for predicting prognosis and drug sensitivity in ovarian cancer based on integrative machine learning
by: Bo Zhao, et al.
Published: (2023-10-01)

Establishment of a novel glycolysis-related prognostic gene signature for ovarian cancer and its relationships with immune infiltration of the tumor microenvironment
by: Jianlei Bi, et al.
Published: (2021-09-01)

A lactate metabolism-related signature predicting patient prognosis and immune microenvironment in ovarian cancer
by: Linhua Zhu, et al.
Published: (2024-03-01)

A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer
by: Jiani Yang, et al.
Published: (2023-09-01)

Analysis of Autophagy-Related Signatures Identified Two Distinct Subtypes for Evaluating the Tumor Immune Microenvironment and Predicting Prognosis in Ovarian Cancer
by: Xingyu Chen, et al.
Published: (2021-05-01)

Construction of immunotherapy-related prognostic gene signature and small molecule drug prediction for cutaneous melanoma
by: Jiahua Xing, et al.
Published: (2022-07-01)

Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer
by: Tianlei Xie, et al.
Published: (2024-02-01)

A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer
by: Jiani Yang, et al.
Published: (2023-04-01)

Role of a Pyroptosis-Related lncRNA Signature in Risk Stratification and Immunotherapy of Ovarian Cancer
by: Zeyu Zhang, et al.
Published: (2022-01-01)

Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer
by: Zitao Wang, et al.
Published: (2022-06-01)

A prognostic signature based on adenosine metabolism related genes for ovarian cancer
by: Weifeng Liang, et al.
Published: (2022-11-01)

Deciphering a Prognostic Signature Based on Soluble Mediators Defines the Immune Landscape and Predicts Prognosis in HNSCC
by: Hao Chi, et al.
Published: (2024-03-01)

Construction and Verification of the Molecular Subtype and a Novel Prognostic Signature Based on Inflammatory Response-Related Genes in Uveal Melanoma
by: Feng Zhang, et al.
Published: (2023-01-01)

Inflammation-Related LncRNAs Signature for Prognosis and Immune Response Evaluation in Uterine Corpus Endometrial Carcinoma
by: Hongmei Gu, et al.
Published: (2022-06-01)

An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma
by: Shi F, et al.
Published: (2021-07-01)

Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps
by: Yanhua Zuo, et al.
Published: (2023-04-01)

Molecular subtypes, clinical significance, and tumor immune landscape of angiogenesis-related genes in ovarian cancer
by: Haixia Tang, et al.
Published: (2022-08-01)

Identifying a novel cuproptosis-related necroptosis gene subtype-related signature for predicting the prognosis, tumor microenvironment, and immunotherapy of hepatocellular carcinoma
by: Yuanxin Shi, et al.
Published: (2023-05-01)

Construction and validation of a RARRES3-based prognostic signature related to the specific immune microenvironment of pancreatic cancer
by: Yimeng Sun, et al.
Published: (2024-02-01)

Integrative Dissection of Novel Lactate Metabolism-Related Signature in the Tumor Immune Microenvironment and Prognostic Prediction in Breast Cancer
by: Lu Yang, et al.
Published: (2022-04-01)

Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma
by: Xiaoyu Mao, et al.
Published: (2023-07-01)

Integration of single-cell and bulk RNA sequencing to establish a prognostic signature based on tumor-associated macrophages in colorectal cancer
by: Hua Li, et al.
Published: (2023-11-01)

Development of a multi-gene-based immune prognostic signature in ovarian Cancer
by: Tiefeng Cao, et al.
Published: (2021-01-01)

Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC
by: Hao Chi, et al.
Published: (2022-10-01)

Identification of CD4+ Conventional T Cells-Related lncRNA Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Breast Cancer
by: Shipeng Ning, et al.
Published: (2022-05-01)

Prognostic Value and Correlation With Tumor Immune Infiltration of a Novel Metabolism-Related Gene Signature in Pancreatic Cancer
by: Hui Chen, et al.
Published: (2022-01-01)

Identification and Validation of a Novel Prognostic Signature Based on Ferroptosis-Related Genes in Ovarian Cancer
by: Zhe Cheng, et al.
Published: (2023-01-01)

Dynamic TF-lncRNA Regulatory Networks Revealed Prognostic Signatures in the Development of Ovarian Cancer
by: Qiuyan Guo, et al.
Published: (2020-05-01)

Identification of a Prognostic Signature Associated With DNA Repair Genes in Ovarian Cancer
by: Hengzi Sun, et al.
Published: (2019-09-01)

Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
by: Shan Hua, et al.
Published: (2022-07-01)

A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy
by: Xiang-Xu Wang, et al.
Published: (2022-09-01)

Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma
by: Lixia Xu, et al.
Published: (2023-03-01)

Construction of immune-related signature and identification of S100A14 determining immune-suppressive microenvironment in pancreatic cancer
by: Chengcheng Wang, et al.
Published: (2022-08-01)

Genomic and immunogenomic analysis of three prognostic signature genes in LUAD
by: Hai-Ming Feng, et al.
Published: (2023-01-01)

Integrative Analysis of KCNK Genes and Establishment of a Specific Prognostic Signature for Breast Cancer
by: Yutian Zou, et al.
Published: (2022-05-01)

Clinical significance and immune infiltration analyses of a novel coagulation-related signature in ovarian cancer
by: Jiani Yang, et al.
Published: (2023-10-01)